The estimated Net Worth of John Barnickel is at least 447$ dollars as of 10 August 2020. John Barnickel owns over 7,300 units of Acutus Medical stock worth over 447$ and over the last 4 years John sold AFIB stock worth over 0$.
John has made over 1 trades of the Acutus Medical stock since 2020, according to the Form 4 filled with the SEC. Most recently John bought 7,300 units of AFIB stock worth 131,400$ on 10 August 2020.
The largest trade John's ever made was buying 7,300 units of Acutus Medical stock on 10 August 2020 worth over 131,400$. On average, John trades about 3,650 units every 0 days since 2020. As of 10 August 2020 John still owns at least 13,966 units of Acutus Medical stock.
You can see the complete history of John Barnickel stock trades at the bottom of the page.
John's mailing address filed with the SEC is C/O ACUTUS MEDICAL, INC., 2210 FARADAY AVE., SUITE 100, CARLSBAD, CA, 92008.
Over the last 4 years, insiders at Acutus Medical have traded over 34,800$ worth of Acutus Medical stock and bought 5,601,584 units worth 87,402,576$ . The most active insiders traders include David P Bonita、James E Deerfield Mgmt Iii,...、Shahzad Malik. On average, Acutus Medical executives and independent directors trade stock every 67 days with the average trade being worth of 18,117$. The most recent stock trade was executed by R Scott Huennekens on 3 June 2022, trading 60,000 units of AFIB stock currently worth 34,800$.
Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. The company's product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.
Acutus Medical executives and other stock owners filed with the SEC include: